Marius C Hoener

13PUBLICATIONS
29CO-AUTHORS
Clinical pharmacology and therapeuticsCharacterisation of biological macromoleculesNeurology and neuromuscular diseasesAutonomic nervous systemPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 04, 2026
Novel selective morpholine trace amine-associated receptor 1 partial agonists show promising preclinical effects for neuropsychiatric disorders and are well tolerated in healthy volunteers.

Céline Fournier, Danièle Buchy, Susanne Mohr

|Nov 05, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Dino Luethi, Grant C Glatfelter, Eline Pottie

|Aug 30, 2025
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.

Ravi Jagasia, Charlotte Bon, Soren V Rasmussen

|Nov 09, 2024
Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission.

Sunmee Park, Jasmine Heu, Marius C Hoener

|Sep 24, 2024
Wakefulness Induced by TAAR1 Partial Agonism is Mediated Through Dopaminergic Neurotransmission.

Sunmee Park, Jasmine Heu, Marius C Hoener

|Aug 31, 2022
Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats.

Daniil Grinchii, Marius C Hoener, Talah Khoury

Pageof 3

Frequent Collaborators

4 joint publications

Thomas S Kilduff

2 joint publications

Sunmee Park

2 joint publications

Matthias E Liechti

1 joint publications

Damiana Leo